How can we identify the most appropriate cellular therapy for each patient?
Myeloma Connect 2021 is a series of live, interactive broadcasts, each focussed on a specific topic relevant to hematologists treating patients with multiple myeloma. The series (July to December 2021) will focus on key issues relating to the management of patients with multiple myeloma.
After participating in this webinar, viewers should be able to:
- Explain how to identify the most appropriate cellular therapy for each patient with multiple myeloma
- Mohamad Mohty (France)
- Paula Rodriguez-Otero (Spain)